Companies: 10,795·Total market cap: $144.5T
PLx Pharma Inc.

PLx Pharma Inc.

PLXPNASDAQHealthcare
$0.09
+$0.00(+0.00%)
Market Cap$2534980
P/E Ratio
52W High$3.41
52W Low$0.009
Overview

PLx Pharma Inc.(PLXP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PLXP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2021-122020-122019-122018-122017-12
Revenue
Revenue$8.21M$0.03M$0.57M$0.75M$0.78M
Cost of Revenue$4.80M$0.00M$0.00M$0.00M$0.00M
Gross Profit$3.40M$0.03M$0.57M$0.75M$0.78M
Gross Margin %(computed)41.46%100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$4.18M$4.34M$4.74M$3.92M$4.16M
G&A Expenses$0.00M$9.15M$10.03M$7.79M$10.17M
Total Operating Expenses$44.19M$13.49M$14.77M$11.71M$14.33M
Operating Income($40.79M)($13.46M)($14.20M)($10.96M)($15.85M)
Operating Margin %(computed)-496.95%
Interest Income$0.00M$0.00M$0.41M$0.30M$0.11M
Interest Expense$0.00M$0.31M$0.99M$1.15M$1.16M
Income Before Tax($46.13M)($15.21M)($20.50M)$0.90M($16.27M)
Income Tax Expense$5.33M($0.11M)$0.84M$0.00M($0.92M)
Net Income($51.46M)($15.10M)($21.34M)$0.90M($15.35M)
Net Margin %(computed)-626.95%119.04%
Per Share & EBITDA
EPS (Basic)$-2.18$-1.55$-2.39$0.10$-2.19
Wtd Avg Shares23.65M9.71M8.92M8.73M7.02M
EBITDA($35.24M)($14.49M)($13.80M)$2.24M($15.10M)
EBITDA Margin %(computed)-429.35%297.86%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解PLx Pharma Inc.

关于PLx Pharma Inc.(PLXP)损益表

PLx Pharma Inc.(PLXP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2021财年,PLXP实现营收$0.01B,毛利润$0.00B(毛利率41.46%),净利润($0.05B)(净利率-626.95%)。

常见问题

PLXP · 4 问

PLx Pharma Inc.(PLXP)2021财年营收为$0.01B,同比up26873.4%。

PLXP revenuePLXP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09